Axovant - Articles and news items

Trial of RVT-101 in Alzheimer’s disease starts at Plymouth Science Park

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+